| Nov 15 |
NTRA
|
Natera, Inc. (NASDAQ:NTRA) Just Reported And Analysts Have Been Lifting Their Price Targets |
| Nov 15 |
NTRA
|
Stanley Druckenmiller's Strategic Emphasis on Natera Inc in Q3 2024 |
| Nov 14 |
NTRA
|
Druckenmiller's Duquesne closes some media holdings, loads into regional banks, among Q3 trades |
| Nov 14 |
NTRA
|
Natera Third Quarter 2024 Earnings: Beats Expectations |
| Nov 13 |
NTRA
|
Natera Stock Explodes 20% After Record-Breaking Q3--Is This Biotech Giant Just Getting Started? |
| Nov 13 |
NTRA
|
Paymentus Posts Better-Than-Expected Earnings, Joins Dave, Honest Company, Natera, CAVA Group And Other Big Stocks Moving Higher On Wednesday |
| Nov 13 |
NTRA
|
Natera Inc (NTRA) Q3 2024 Earnings Call Highlights: Record Revenue and Raised Guidance Amid ... |
| Nov 13 |
NTRA
|
Decoding Natera Inc (NTRA): A Strategic SWOT Insight |
| Nov 13 |
NTRA
|
Natera, Inc. (NTRA) Q3 2024 Earnings Call Transcript |
| Nov 12 |
NTRA
|
Natera (NTRA) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates |
| Nov 12 |
NTRA
|
Natera (NTRA) Reports Q3 Loss, Tops Revenue Estimates |
| Nov 12 |
NTRA
|
Natera stock jumps 11% post-market on Q3 earnings, raised guidance |
| Nov 12 |
NTRA
|
Natera: Q3 Earnings Snapshot |
| Nov 12 |
NTRA
|
Natera GAAP EPS of -$0.26 beats by $0.33, revenue of $439.76M beats by $78.63M |
| Nov 12 |
NTRA
|
Natera Reports Third Quarter 2024 Financial Results |
| Nov 12 |
NTRA
|
Natera Announces Completion of Signatera™ Analysis from the CALGB (Alliance)/SWOG 80702 Randomized, Phase III Clinical Trial in Colorectal Cancer |
| Nov 12 |
NTRA
|
Earnings Scheduled For November 12, 2024 |
| Nov 11 |
NTRA
|
Natera Q3 2024 Earnings Preview |
